Benjamin L. Oakes
Chief Executive Officer, Scribe Therapeutics, Inc.
Companies
- Scribe Therapeutics, Inc.Board member Jul 23, 2026 to now1
- Scribe Therapeutics, Inc.Chief executive officer Jul 23, 2026 to now1
- Scribe Therapeutics, Inc.President Jul 23, 2026 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Scribe Therapeutics, Inc. SCTX506,602 shares2$10.6M at $20.93Jul 23, 2026
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2